{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T18:48:46Z","timestamp":1743014926974,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":111,"publisher":"Springer Nature Singapore","isbn-type":[{"type":"print","value":"9789819914425"},{"type":"electronic","value":"9789819914432"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-99-1443-2_9","type":"book-chapter","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T09:02:43Z","timestamp":1692608563000},"page":"129-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Extracellular Vesicles and Fatty Liver"],"prefix":"10.1007","author":[{"given":"Xiya","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyi","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"issue":"1","key":"9_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MOL.0000000000000141","volume":"26","author":"M Koch","year":"2015","unstructured":"Koch M, Nothlings U, Lieb W (2015) Dietary patterns and fatty liver disease. Curr Opin Lipidol 26(1):35\u201341","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"9_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S (2018) Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol 68(2):268\u2013279","journal-title":"J Hepatol"},{"issue":"1","key":"9_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15(1):11\u201320","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"9_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s12072-020-10038-w","volume":"14","author":"M Sayiner","year":"2020","unstructured":"Sayiner M, Arshad T, Golabi P, Paik J, Farhat F, Younossi ZM (2020) Extrahepatic manifestations and healthcare expenditures of non-alcoholic fatty liver disease in the medicare population. Hepatol Int 14(4):556\u2013566","journal-title":"Hepatol Int"},{"issue":"7","key":"9_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24(7):908\u2013922","journal-title":"Nat Med"},{"issue":"4","key":"9_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","volume":"13","author":"ME Rinella","year":"2016","unstructured":"Rinella ME, Sanyal AJ (2016) Management of NAFLD: a stage-based approach. Nat Rev Gastroenterol Hepatol 13(4):196\u2013205","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"9_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000341127","volume":"30","author":"EM Brunt","year":"2012","unstructured":"Brunt EM (2012) Nonalcoholic fatty liver disease: what the pathologist can tell the clinician. Dig Dis 30(Suppl 1):61\u201368","journal-title":"Dig Dis"},{"issue":"6","key":"9_CR8","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/gutjnl-2019-318841","volume":"69","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wong GL, He FP, Sun J, Chan AW, Yang J, Shu SS, Liang X, Tse YK, Fan XT, Hou J, Chan HL, Wong VW (2020) Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy. Gut 69(6):1116\u20131126","journal-title":"Gut"},{"issue":"3","key":"9_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/s-0035-1562942","volume":"35","author":"AD Burt","year":"2015","unstructured":"Burt AD, Lackner C, Tiniakos DG (2015) Diagnosis and assessment of NAFLD: definitions and histopathological classification. Semin Liver Dis 35(3):207\u2013220","journal-title":"Semin Liver Dis"},{"issue":"2","key":"9_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, Friedman SL, Diago M, Romero-Gomez M (2015) Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149(2):367\u2013378.e365; quiz e314-365","journal-title":"Gastroenterology"},{"issue":"4","key":"9_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jhep.2016.05.026","volume":"65","author":"KC Sung","year":"2016","unstructured":"Sung KC, Ryu S, Lee JY, Kim JY, Wild SH, Byrne CD (2016) Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver. J Hepatol 65(4):791\u2013797","journal-title":"J Hepatol"},{"issue":"8","key":"9_CR12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/apt.15989","volume":"52","author":"P O\u2019Gorman","year":"2020","unstructured":"O\u2019Gorman P, Naimimohasses S, Monaghan A, Kennedy M, Melo AM, Ni Fhloinn D, Doherty DG, Beddy P, Finn SP, Moore JB, Gormley J, Norris S (2020) Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention. Aliment Pharmacol Ther 52(8):1387\u20131398","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"9_CR13","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","volume":"68","author":"M Gjorgjieva","year":"2019","unstructured":"Gjorgjieva M, Sobolewski C, Dolicka D, Correia de Sousa M, Foti M (2019) miRNAs and NAFLD: from pathophysiology to therapy. Gut 68(11):2065\u20132079","journal-title":"Gut"},{"issue":"9","key":"9_CR14","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1039\/D0FO01095B","volume":"11","author":"XF Guo","year":"2020","unstructured":"Guo XF, Wang C, Yang T, Li S, Li KL, Li D (2020) Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Food Funct 11(9):7389\u20137399","journal-title":"Food Funct"},{"issue":"2","key":"9_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/hep.30368","volume":"71","author":"E Vilar-Gomez","year":"2020","unstructured":"Vilar-Gomez E, Vuppalanchi R, Gawrieh S, Ghabril M, Saxena R, Cummings OW, Chalasani N (2020) Vitamin E improves transplant-free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis. Hepatology 71(2):495\u2013509","journal-title":"Hepatology"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nut.2018.02.021","volume":"57","author":"S Rezaei","year":"2019","unstructured":"Rezaei S, Akhlaghi M, Sasani MR, Barati Boldaji R (2019) Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Nutrition 57:154\u2013161","journal-title":"Nutrition"},{"issue":"2","key":"9_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.clnu.2016.12.009","volume":"37","author":"LH Chen","year":"2018","unstructured":"Chen LH, Wang YF, Xu QH, Chen SS (2018) Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 37(2):516\u2013521","journal-title":"Clin Nutr"},{"issue":"1","key":"9_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","volume":"62","author":"CK Argo","year":"2015","unstructured":"Argo CK, Patrie JT, Lackner C, Henry TD, de Lange EE, Weltman AL, Shah NL, Al-Osaimi AM, Pramoonjago P, Jayakumar S, Binder LP, Simmons-Egolf WD, Burks SG, Bao Y, Taylor AG, Rodriguez J, Caldwell SH (2015) Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial. J Hepatol 62(1):190\u2013197","journal-title":"J Hepatol"},{"issue":"8","key":"9_CR19","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1210\/jc.2017-00867","volume":"102","author":"F Bril","year":"2017","unstructured":"Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Hecht J, Tio F, Cusi K (2017) Liver safety of statins in prediabetes or T2DM and nonalcoholic steatohepatitis: post hoc analysis of a randomized trial. J Clin Endocrinol Metab 102(8):2950\u20132961","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"9_CR20","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR, Nash CRN (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362(18):1675\u20131685","journal-title":"N Engl J Med"},{"issue":"3","key":"9_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tcb.2016.11.003","volume":"27","author":"SLN Maas","year":"2017","unstructured":"Maas SLN, Breakefield XO, Weaver AM (2017) Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol 27(3):172\u2013188","journal-title":"Trends Cell Biol"},{"issue":"4","key":"9_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213\u2013228","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"9_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","volume":"30","author":"A Becker","year":"2016","unstructured":"Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D (2016) Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30(6):836\u2013848","journal-title":"Cancer Cell"},{"issue":"2","key":"9_CR24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms17020171","volume":"17","author":"N Iraci","year":"2016","unstructured":"Iraci N, Leonardi T, Gessler F, Vega B, Pluchino S (2016) Focus on extracellular vesicles: physiological role and signalling properties of extracellular membrane vesicles. Int J Mol Sci 17(2):171","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/vaccines7030102","volume":"7","author":"L Urbanelli","year":"2019","unstructured":"Urbanelli L, Buratta S, Tancini B, Sagini K, Delo F, Porcellati S, Emiliani C (2019) The role of extracellular vesicles in viral infection and transmission. Vaccines (Basel) 7(3):102","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"9_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.tem.2016.10.003","volume":"28","author":"I Huang-Doran","year":"2017","unstructured":"Huang-Doran I, Zhang CY, Vidal-Puig A (2017) Extracellular vesicles: novel mediators of cell communication in metabolic disease. Trends Endocrinol Metab 28(1):3\u201318","journal-title":"Trends Endocrinol Metab"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255\u2013289","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"9_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.clinthera.2014.04.019","volume":"36","author":"G Natasha","year":"2014","unstructured":"Natasha G, Gundogan B, Tan A, Farhatnia Y, Wu W, Rajadas J, Seifalian AM (2014) Exosomes as immunotheranostic nanoparticles. Clin Ther 36(6):820\u2013829","journal-title":"Clin Ther"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","volume":"188","author":"MP Bebelman","year":"2018","unstructured":"Bebelman MP, Smit MJ, Pegtel DM, Baglio SR (2018) Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther 188:1\u201311","journal-title":"Pharmacol Ther"},{"issue":"3","key":"9_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R (2012) Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64(3):676\u2013705","journal-title":"Pharmacol Rev"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/978-1-4939-7253-1_35","volume":"1660","author":"J Liu","year":"2017","unstructured":"Liu J, Ma J, Tang K, Huang B (2017) Therapeutic use of tumor cell-derived extracellular vesicles. Methods Mol Biol 1660:433\u2013440","journal-title":"Methods Mol Biol"},{"issue":"18","key":"9_CR32","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.3390\/ijms21186486","volume":"21","author":"S Martellucci","year":"2020","unstructured":"Martellucci S, Orefice NS, Angelucci A, Luce A, Caraglia M, Zappavigna S (2020) Extracellular vesicles: new endogenous shuttles for miRNAs in cancer diagnosis and therapy? Int J Mol Sci 21(18):6486","journal-title":"Int J Mol Sci"},{"issue":"4","key":"9_CR33","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1021\/acs.chemrev.7b00534","volume":"118","author":"H Shao","year":"2018","unstructured":"Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H (2018) New technologies for analysis of extracellular vesicles. Chem Rev 118(4):1917\u20131950","journal-title":"Chem Rev"},{"issue":"12","key":"9_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrneph.2017.148","volume":"13","author":"ML Merchant","year":"2017","unstructured":"Merchant ML, Rood IM, Deegens JKJ, Klein JB (2017) Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat Rev Nephrol 13(12):731\u2013749","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"9_CR35","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMra1704286","volume":"379","author":"R Shah","year":"2018","unstructured":"Shah R, Patel T, Freedman JE (2018) Circulating extracellular vesicles in human disease. N Engl J Med 379(10):958\u2013966","journal-title":"N Engl J Med"},{"issue":"1","key":"9_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0005-2736(81)90512-5","volume":"645","author":"EG Trams","year":"1981","unstructured":"Trams EG, Lauter CJ, Salem N Jr, Heine U (1981) Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 645(1):63\u201370","journal-title":"Biochim Biophys Acta"},{"issue":"7576","key":"9_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, Wang H, Ellis K, Cheerathodi M, McCarty JH, Palmieri D, Saunus J, Lakhani S, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D (2015) Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527(7576):100\u2013104","journal-title":"Nature"},{"issue":"5","key":"9_CR38","doi-asserted-by":"publisher","first-page":"478.e471","DOI":"10.1016\/j.ajog.2018.08.021","volume":"219","author":"EE Hadley","year":"2018","unstructured":"Hadley EE, Sheller-Miller S, Saade G, Salomon C, Mesiano S, Taylor RN, Taylor BD, Menon R (2018) Amnion epithelial cell-derived exosomes induce inflammatory changes in uterine cells. Am J Obstet Gynecol 219(5):478.e471\u2013478.e421","journal-title":"Am J Obstet Gynecol"},{"issue":"15","key":"9_CR39","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.3390\/ijms20153733","volume":"20","author":"E Kobayashi","year":"2019","unstructured":"Kobayashi E, Hwang D, Bheda-Malge A, Whitehurst CB, Kabanov AV, Kondo S, Aga M, Yoshizaki T, Pagano JS, Sokolsky M, Shakelford J (2019) Inhibition of UCH-L1 deubiquitinating activity with two forms of LDN-57444 has anti-invasive effects in metastatic carcinoma cells. Int J Mol Sci 20(15):3733","journal-title":"Int J Mol Sci"},{"issue":"5","key":"9_CR40","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1517\/17425251003614766","volume":"6","author":"J Conde-Vancells","year":"2010","unstructured":"Conde-Vancells J, Gonzalez E, Lu SC, Mato JM, Falcon-Perez JM (2010) Overview of extracellular microvesicles in drug metabolism. Expert Opin Drug Metab Toxicol 6(5):543\u2013554","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-015-0426-x","volume":"14","author":"A Conigliaro","year":"2015","unstructured":"Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, Manno M, Raccosta S, Mancone C, Tripodi M, De Leo G, Alessandro R (2015) CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer 14:155","journal-title":"Mol Cancer"},{"issue":"8","key":"9_CR42","doi-asserted-by":"publisher","first-page":"961","DOI":"10.7150\/ijbs.11943","volume":"11","author":"A Huang","year":"2015","unstructured":"Huang A, Dong J, Li S, Wang C, Ding H, Li H, Su X, Ge X, Sun L, Bai C, Shen X, Fang T, Li J, Shao N (2015) Exosomal transfer of vasorin expressed in hepatocellular carcinoma cells promotes migration of human umbilical vein endothelial cells. Int J Biol Sci 11(8):961\u2013969","journal-title":"Int J Biol Sci"},{"issue":"9","key":"9_CR43","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1093\/carcin\/bgv081","volume":"36","author":"M He","year":"2015","unstructured":"He M, Qin H, Poon TC, Sze SC, Ding X, Co NN, Ngai SM, Chan TF, Wong N (2015) Hepatocellular carcinoma-derived exosomes promote motility of immortalized hepatocyte through transfer of oncogenic proteins and RNAs. Carcinogenesis 36(9):1008\u20131018","journal-title":"Carcinogenesis"},{"issue":"1","key":"9_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-016-0430-z","volume":"35","author":"Z Qu","year":"2016","unstructured":"Qu Z, Wu J, Wu J, Luo D, Jiang C, Ding Y (2016) Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro. J Exp Clin Cancer Res 35(1):159","journal-title":"J Exp Clin Cancer Res"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fimmu.2016.00335","volume":"7","author":"T Kouwaki","year":"2016","unstructured":"Kouwaki T, Fukushima Y, Daito T, Sanada T, Yamamoto N, Mifsud EJ, Leong CR, Tsukiyama-Kohara K, Kohara M, Matsumoto M, Seya T, Oshiumi H (2016) Extracellular vesicles including exosomes regulate innate immune responses to hepatitis B virus infection. Front Immunol 7:335","journal-title":"Front Immunol"},{"issue":"Pt 7","key":"9_CR46","first-page":"1585","volume":"127","author":"K Takahashi","year":"2014","unstructured":"Takahashi K, Yan IK, Haga H, Patel T (2014a) Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci 127(Pt 7):1585\u20131594","journal-title":"J Cell Sci"},{"issue":"10","key":"9_CR47","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1158\/1541-7786.MCR-13-0636","volume":"12","author":"K Takahashi","year":"2014","unstructured":"Takahashi K, Yan IK, Wood J, Haga H, Patel T (2014b) Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Mol Cancer Res 12(10):1377\u20131387","journal-title":"Mol Cancer Res"},{"issue":"1","key":"9_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cld.2018.09.011","volume":"23","author":"PD Axley","year":"2019","unstructured":"Axley PD, Richardson CT, Singal AK (2019) Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease. Clin Liver Dis 23(1):39\u201350","journal-title":"Clin Liver Dis"},{"key":"9_CR49","unstructured":"Patel R, Mueller M (2021) Alcoholic liver disease. In: StatPearls. Treasure Island (FL)"},{"issue":"8","key":"9_CR50","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.alcohol.2012.08.004","volume":"46","author":"E Brandon-Warner","year":"2012","unstructured":"Brandon-Warner E, Schrum LW, Schmidt CM, McKillop IH (2012) Rodent models of alcoholic liver disease: of mice and men. Alcohol 46(8):715\u2013725","journal-title":"Alcohol"},{"issue":"5","key":"9_CR51","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R (2011) Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141(5):1572\u20131585","journal-title":"Gastroenterology"},{"issue":"2","key":"9_CR52","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3350\/cmh.2017.0067","volume":"24","author":"AM Cassard","year":"2018","unstructured":"Cassard AM, Ciocan D (2018) Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol 24(2):100\u2013107","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"9_CR53","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1142\/S0192415X16500671","volume":"44","author":"L Tang","year":"2016","unstructured":"Tang L, Yang F, Fang Z, Hu C (2016) Resveratrol ameliorates alcoholic fatty liver by inducing autophagy. Am J Chin Med 44(6):1207\u20131220","journal-title":"Am J Chin Med"},{"issue":"2","key":"9_CR54","first-page":"147","volume":"38","author":"NA Osna","year":"2017","unstructured":"Osna NA, Donohue TM Jr, Kharbanda KK (2017) Alcoholic liver disease: pathogenesis and current management. Alcohol Res 38(2):147\u2013161","journal-title":"Alcohol Res"},{"issue":"1","key":"9_CR55","first-page":"9","volume":"7","author":"F Magdaleno","year":"2017","unstructured":"Magdaleno F, Blajszczak CC, Nieto N (2017) Key events participating in the pathogenesis of alcoholic liver disease. Biomol Ther 7(1):9","journal-title":"Biomol Ther"},{"issue":"6","key":"9_CR56","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke F (2017) Targeting hepatic macrophages to treat liver diseases. J Hepatol 66(6):1300\u20131312","journal-title":"J Hepatol"},{"issue":"7","key":"9_CR57","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.4049\/jimmunol.1402190","volume":"194","author":"B Saha","year":"2015","unstructured":"Saha B, Bruneau JC, Kodys K, Szabo G (2015) Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes. J Immunol 194(7):3079\u20133087","journal-title":"J Immunol"},{"issue":"1","key":"9_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1074\/jbc.M115.694133","volume":"291","author":"B Saha","year":"2016","unstructured":"Saha B, Momen-Heravi F, Kodys K, Szabo G (2016) MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J Biol Chem 291(1):149\u2013159","journal-title":"J Biol Chem"},{"issue":"3","key":"9_CR59","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jhep.2015.11.020","volume":"64","author":"VK Verma","year":"2016","unstructured":"Verma VK, Li H, Wang R, Hirsova P, Mushref M, Liu Y, Cao S, Contreras PC, Malhi H, Kamath PS, Gores GJ, Shah VH (2016) Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles. J Hepatol 64(3):651\u2013660","journal-title":"J Hepatol"},{"issue":"3","key":"9_CR60","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M (2020) The gut-liver axis in liver disease: pathophysiological basis for therapy. J Hepatol 72(3):558\u2013577","journal-title":"J Hepatol"},{"issue":"4","key":"9_CR61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS (2019) Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol 16(4):235\u2013246","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7783","key":"9_CR62","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","volume":"575","author":"Y Duan","year":"2019","unstructured":"Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M, Shao Y, Liu J, Hernandez-Morales A, Lessor L, Rahman IR, Miyamoto Y, Ly M, Gao B, Sun W, Kiesel R, Hutmacher F, Lee S, Ventura-Cots M, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS Jr, Vargas V, Altamirano J, Caballeria J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Bataller R, Tu XM, Eckmann L, van der Donk WA, Young R, Lawley TD, Starkel P, Pride D, Fouts DE, Schnabl B (2019) Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575(7783):505\u2013511","journal-title":"Nature"},{"issue":"6","key":"9_CR63","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/hep.28814","volume":"64","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, Ibrahim SH, Verma VK, Morton LA, Shah VH, LaRusso NF, Gores GJ, Malhi H (2016a) Extracellular vesicles in liver pathobiology: small particles with big impact. Hepatology 64(6):2219\u20132233","journal-title":"Hepatology"},{"issue":"4","key":"9_CR64","first-page":"358","volume":"52","author":"ZX Peng","year":"2018","unstructured":"Peng ZX, Zou MY, Xu J, Guan WY, Li Y, Liu DR, Zhang SS, Hao Q, Yan SF, Wang W, Yu DM, Li FQ (2018) Antimicrobial susceptibility and drug-resistance genes of Yersinia spp. of retailed poultry in 4 provinces of China. Zhonghua Yu Fang Yi Xue Za Zhi 52(4):358\u2013363","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"3","key":"9_CR65","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/hep.28252","volume":"63","author":"SH Ibrahim","year":"2016","unstructured":"Ibrahim SH, Hirsova P, Tomita K, Bronk SF, Werneburg NW, Harrison SA, Goodfellow VS, Malhi H, Gores GJ (2016) Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes. Hepatology 63(3):731\u2013744","journal-title":"Hepatology"},{"issue":"4","key":"9_CR66","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","volume":"150","author":"P Hirsova","year":"2016","unstructured":"Hirsova P, Ibrahim SH, Krishnan A, Verma VK, Bronk SF, Werneburg NW, Charlton MR, Shah VH, Malhi H, Gores GJ (2016b) Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes. Gastroenterology 150(4):956\u2013967","journal-title":"Gastroenterology"},{"key":"9_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116829","volume":"235","author":"X Chen","year":"2019","unstructured":"Chen X, Tan XR, Li SJ, Zhang XX (2019) LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p\/ROCK1 in nonalcoholic fatty liver disease. Life Sci 235:116829","journal-title":"Life Sci"},{"issue":"12","key":"9_CR68","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1172\/JCI63562","volume":"128","author":"H Huang","year":"2018","unstructured":"Huang H, Lee SH, Sousa-Lima I, Kim SS, Hwang WM, Dagon Y, Yang WM, Cho S, Kang MC, Seo JA, Shibata M, Cho H, Belew GD, Bhin J, Desai BN, Ryu MJ, Shong M, Li P, Meng H, Chung BH, Hwang D, Kim MS, Park KS, Macedo MP, White M, Jones J, Kim YB (2018) Rho-kinase\/AMPK axis regulates hepatic lipogenesis during overnutrition. J Clin Invest 128(12):5335\u20135350","journal-title":"J Clin Invest"},{"issue":"2","key":"9_CR69","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1194\/jlr.M063412","volume":"57","author":"E Kakazu","year":"2016","unstructured":"Kakazu E, Mauer AS, Yin M, Malhi H (2016) Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1alpha-dependent manner. J Lipid Res 57(2):233\u2013245","journal-title":"J Lipid Res"},{"issue":"9733","key":"9_CR70","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","volume":"375","author":"VT Samuel","year":"2010","unstructured":"Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375(9733):2267\u20132277","journal-title":"Lancet"},{"issue":"1","key":"9_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384","journal-title":"Hepatology"},{"issue":"11","key":"9_CR72","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Day CP (2013) The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 10(11):645\u2013655","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"9_CR73","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s12072-013-9446-z","volume":"7","author":"P Bedossa","year":"2013","unstructured":"Bedossa P (2013) Current histological classification of NAFLD: strength and limitations. Hepatol Int 7(Suppl 2):765\u2013770","journal-title":"Hepatol Int"},{"issue":"5","key":"9_CR74","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH (2019) Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 4(5):389\u2013398","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"9_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ (2018) Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67(1):123\u2013133","journal-title":"Hepatology"},{"issue":"5","key":"9_CR76","first-page":"65","volume":"9","author":"J Makker","year":"2019","unstructured":"Makker J, Tariq H, Bella JN, Kumar K, Chime C, Patel H, Kamal MU, Shaikh D, Vootla V, Bajantri B, Gomceli U, Alshelleh M, Peralta R, Zhang A, Chilimuri S (2019) Preclinical cardiac disease in nonalcoholic fatty liver disease with and without metabolic syndrome. Am J Cardiovasc Dis 9(5):65\u201377","journal-title":"Am J Cardiovasc Dis"},{"issue":"4","key":"9_CR77","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW (2017) New trends on obesity and NAFLD in Asia. J Hepatol 67(4):862\u2013873","journal-title":"J Hepatol"},{"issue":"10","key":"9_CR78","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s00535-003-1178-8","volume":"38","author":"S Kojima","year":"2003","unstructured":"Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S (2003) Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 38(10):954\u2013961","journal-title":"J Gastroenterol"},{"issue":"5","key":"9_CR79","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H (2020) Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology 71(5):1851\u20131864","journal-title":"Hepatology"},{"issue":"2","key":"9_CR80","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","volume":"14","author":"F Marra","year":"2008","unstructured":"Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C (2008) Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14(2):72\u201381","journal-title":"Trends Mol Med"},{"issue":"2 Suppl 1","key":"9_CR81","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43(2 Suppl 1):S99\u2013S112","journal-title":"Hepatology"},{"issue":"1","key":"9_CR82","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.29777","volume":"68","author":"Y Cai","year":"2018","unstructured":"Cai Y, Li H, Liu M, Pei Y, Zheng J, Zhou J, Luo X, Huang W, Ma L, Yang Q, Guo S, Xiao X, Li Q, Zeng T, Meng F, Francis H, Glaser S, Chen L, Huo Y, Alpini G, Wu C (2018) Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity. Hepatology 68(1):48\u201361","journal-title":"Hepatology"},{"issue":"3","key":"9_CR83","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier M, Leleu H, Peck-Radosavljevic M, Valla DC, Roudot-Thoraval F (2013) The burden of liver disease in Europe: a review of available epidemiological data. J Hepatol 58(3):593\u2013608","journal-title":"J Hepatol"},{"issue":"6","key":"9_CR84","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40(6):1387\u20131395","journal-title":"Hepatology"},{"issue":"8","key":"9_CR85","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.metabol.2015.09.017","volume":"65","author":"A Lonardo","year":"2016","unstructured":"Lonardo A, Sookoian S, Pirola CJ, Targher G (2016) Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism 65(8):1136\u20131150","journal-title":"Metabolism"},{"issue":"8","key":"9_CR86","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8):1038\u20131048","journal-title":"Metabolism"},{"issue":"296","key":"9_CR87","doi-asserted-by":"publisher","first-page":"ra88","DOI":"10.1126\/scisignal.2004512","volume":"6","author":"D Povero","year":"2013","unstructured":"Povero D, Eguchi A, Niesman IR, Andronikou N, de Mollerat du Jeu X, Mulya A, Berk M, Lazic M, Thapaliya S, Parola M, Patel HH, Feldstein AE (2013) Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells. Sci Signal 6(296):ra88","journal-title":"Sci Signal"},{"issue":"6","key":"9_CR88","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","volume":"1","author":"D Povero","year":"2015","unstructured":"Povero D, Panera N, Eguchi A, Johnson CD, Papouchado BG, de Araujo HL, Pinatel EM, Alisi A, Nobili V, Feldstein AE (2015) Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-gamma. Cell Mol Gastroenterol Hepatol 1(6):646\u2013663.e644","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"9_CR89","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mam.2017.11.001","volume":"60","author":"PB Devhare","year":"2018","unstructured":"Devhare PB, Ray RB (2018) Extracellular vesicles: novel mediator for cell to cell communications in liver pathogenesis. Mol Aspects Med 60:115\u2013122","journal-title":"Mol Aspects Med"},{"issue":"2","key":"9_CR90","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1053\/j.gastro.2012.04.031","volume":"143","author":"M Kornek","year":"2012","unstructured":"Kornek M, Lynch M, Mehta SH, Lai M, Exley M, Afdhal NH, Schuppan D (2012) Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 143(2):448\u2013458","journal-title":"Gastroenterology"},{"issue":"12","key":"9_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113651","volume":"9","author":"D Povero","year":"2014","unstructured":"Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A, Messer K, Feldstein AE (2014) Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PloS One 9(12):e113651","journal-title":"PloS One"},{"issue":"11","key":"9_CR92","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1017\/S0007114515001117","volume":"113","author":"LF Heinrich","year":"2015","unstructured":"Heinrich LF, Andersen DK, Cleasby ME, Lawson C (2015) Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells. Br J Nutr 113(11):1704\u20131711","journal-title":"Br J Nutr"},{"issue":"7","key":"9_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070599","volume":"8","author":"P Hirsova","year":"2013","unstructured":"Hirsova P, Ibrahim SH, Bronk SF, Yagita H, Gores GJ (2013) Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PloS One 8(7):e70599","journal-title":"PloS One"},{"key":"9_CR94","doi-asserted-by":"publisher","first-page":"e125652","DOI":"10.1172\/jci.insight.125652","volume":"5","author":"D Povero","year":"2019","unstructured":"Povero D, Pinatel EM, Leszczynska A, Goyal NP, Nishio T, Kim J, Kneiber D, de Araujo HL, Eguchi A, Ordonez PM, Kisseleva T, Feldstein AE (2019) Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis. JCI Insight 5:e125652","journal-title":"JCI Insight"},{"issue":"1","key":"9_CR95","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13287-019-1539-8","volume":"11","author":"L Dong","year":"2020","unstructured":"Dong L, Pu Y, Chen X, Qi X, Zhang L, Xu L, Li W, Ma Y, Zhou S, Zhu J, Li Y, Wang X, Su C (2020) hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice. Stem Cell Res Ther 11(1):21","journal-title":"Stem Cell Res Ther"},{"issue":"12","key":"9_CR96","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1111\/liv.14675","volume":"40","author":"S Yamamura","year":"2020","unstructured":"Yamamura S, Eslam M, Kawaguchi T, Tsutsumi T, Nakano D, Yoshinaga S, Takahashi H, Anzai K, George J, Torimura T (2020) MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int 40(12):3018\u20133030","journal-title":"Liver Int"},{"issue":"52","key":"9_CR97","doi-asserted-by":"publisher","first-page":"30684","DOI":"10.1074\/jbc.M115.671735","volume":"290","author":"R Wang","year":"2015","unstructured":"Wang R, Ding Q, Yaqoob U, de Assuncao TM, Verma VK, Hirsova P, Cao S, Mukhopadhyay D, Huebert RC, Shah VH (2015) Exosome adherence and internalization by hepatic stellate cells triggers sphingosine 1-phosphate-dependent migration. J Biol Chem 290(52):30684\u201330696","journal-title":"J Biol Chem"},{"issue":"6","key":"9_CR98","doi-asserted-by":"publisher","first-page":"G491","DOI":"10.1152\/ajpgi.00140.2015","volume":"309","author":"L Chen","year":"2015","unstructured":"Chen L, Chen R, Kemper S, Charrier A, Brigstock DR (2015) Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: role of exosomes in horizontal transfer of Twist1. Am J Physiol Gastrointest Liver Physiol 309(6):G491\u2013G499","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"9_CR99","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/jcmm.12950","volume":"21","author":"J Shen","year":"2017","unstructured":"Shen J, Huang CK, Yu H, Shen B, Zhang Y, Liang Y, Li Z, Feng X, Zhao J, Duan L, Cai X (2017) The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma. J Cell Mol Med 21(5):986\u2013992","journal-title":"J Cell Mol Med"},{"issue":"12","key":"9_CR100","doi-asserted-by":"publisher","first-page":"14254","DOI":"10.1096\/fj.201901347RR","volume":"33","author":"L Zhou","year":"2019","unstructured":"Zhou L, Li Q, Chen A, Liu N, Chen N, Chen X, Zhu L, Xia B, Gong Y, Chen X (2019) KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF-kappaB-FGF21 or SREBP1c-FGF21 pathway. FASEB J 33(12):14254\u201314269","journal-title":"FASEB J"},{"issue":"1","key":"9_CR101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12944-021-01458-0","volume":"20","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ge X, Li Y, Zhang B, Wang P, Hao M, Gao P, Zhao Y, Sun T, Lu S, Ma W (2021) TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis. Lipids Health Dis 20(1):39","journal-title":"Lipids Health Dis"},{"issue":"3","key":"9_CR102","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/ijms17030376","volume":"17","author":"LA Ban","year":"2016","unstructured":"Ban LA, Shackel NA, McLennan SV (2016) Extracellular vesicles: a new frontier in biomarker discovery for non-alcoholic fatty liver disease. Int J Mol Sci 17(3):376","journal-title":"Int J Mol Sci"},{"issue":"8","key":"9_CR103","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","volume":"15","author":"VW Wong","year":"2018","unstructured":"Wong VW, Adams LA, de Ledinghen V, Wong GL, Sookoian S (2018) Noninvasive biomarkers in NAFLD and NASH\u2014current progress and future promise. Nat Rev Gastroenterol Hepatol 15(8):461\u2013478","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"9_CR104","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1194\/jlr.P056002","volume":"56","author":"DL Gorden","year":"2015","unstructured":"Gorden DL, Myers DS, Ivanova PT, Fahy E, Maurya MR, Gupta S, Min J, Spann NJ, McDonald JG, Kelly SL, Duan J, Sullards MC, Leiker TJ, Barkley RM, Quehenberger O, Armando AM, Milne SB, Mathews TP, Armstrong MD, Li C, Melvin WV, Clements RH, Washington MK, Mendonsa AM, Witztum JL, Guan Z, Glass CK, Murphy RC, Dennis EA, Merrill AH Jr, Russell DW, Subramaniam S, Brown HA (2015) Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. J Lipid Res 56(3):722\u2013736","journal-title":"J Lipid Res"},{"issue":"2","key":"9_CR105","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","volume":"68","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez E, Chalasani N (2018) Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol 68(2):305\u2013315","journal-title":"J Hepatol"},{"issue":"24","key":"9_CR106","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.3748\/wjg.v25.i24.3009","volume":"25","author":"JM Mato","year":"2019","unstructured":"Mato JM, Alonso C, Noureddin M, Lu SC (2019) Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J Gastroenterol 25(24):3009\u20133020","journal-title":"World J Gastroenterol"},{"issue":"10","key":"9_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048366","volume":"7","author":"Y Murakami","year":"2012","unstructured":"Murakami Y, Toyoda H, Tanahashi T, Tanaka J, Kumada T, Yoshioka Y, Kosaka N, Ochiya T, Taguchi YH (2012) Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease. PloS One 7(10):e48366","journal-title":"PloS One"},{"issue":"9","key":"9_CR108","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1111\/liv.12827","volume":"35","author":"H Ajamieh","year":"2015","unstructured":"Ajamieh H, Farrell GC, McCuskey RS, Yu J, Chu E, Wong HJ, Lam W, Teoh NC (2015) Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation. Liver Int 35(9):2174\u20132186","journal-title":"Liver Int"},{"issue":"5","key":"9_CR109","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/hep.25873","volume":"56","author":"S Bala","year":"2012","unstructured":"Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J, Alao H, Kodys K, Szabo G (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56(5):1946\u20131957","journal-title":"Hepatology"},{"issue":"2","key":"9_CR110","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/liv.12633","volume":"35","author":"T Csak","year":"2015","unstructured":"Csak T, Bala S, Lippai D, Satishchandran A, Catalano D, Kodys K, Szabo G (2015) microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int 35(2):532\u2013541","journal-title":"Liver Int"},{"key":"9_CR111","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cca.2015.05.002","volume":"446","author":"H Yamada","year":"2015","unstructured":"Yamada H, Ohashi K, Suzuki K, Munetsuna E, Ando Y, Yamazaki M, Ishikawa H, Ichino N, Teradaira R, Hashimoto S (2015) Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease. Clin Chim Acta 446:267\u2013271","journal-title":"Clin Chim Acta"}],"container-title":["Advances in Experimental Medicine and Biology","Extracellular Vesicles in Cardiovascular and Metabolic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-99-1443-2_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T11:45:29Z","timestamp":1702986329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-99-1443-2_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789819914425","9789819914432"],"references-count":111,"URL":"https:\/\/doi.org\/10.1007\/978-981-99-1443-2_9","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"22 August 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}